Management of type 2 diabetes: the current situation and key opportunities to improve care in the UK. (Q38918743)

7 September 2017

1 reference

title

Management of type 2 diabetes: the current situation and key opportunities to improve care in the UK. (English)

1 reference

7 September 2017

1 reference

S C Bain

1

1 reference

7 September 2017

M Feher

series ordinal

2

1 reference

7 September 2017

D Russell-Jones

series ordinal

3

1 reference

7 September 2017

K Khunti

series ordinal

4

1 reference

7 September 2017

5 August 2016

1 reference

Diabetes, Obesity and Metabolism

7 September 2017

1 reference

7 September 2017

18

1 reference

7 September 2017

1157-1166

1 reference

7 September 2017

12

1 reference

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

7 September 2017

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

21 January 2018

1 reference

Diabetes mellitus, fasting glucose, and risk of cause-specific death

21 January 2018

1 reference

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes

21 January 2018

1 reference

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

21 January 2018

1 reference

Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality

21 January 2018

1 reference

Body-mass index and mortality among adults with incident type 2 diabetes

21 January 2018

1 reference

The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies

21 January 2018

1 reference

Adherence to the DASH Diet is inversely associated with incidence of type 2 diabetes: the insulin resistance atherosclerosis study

21 January 2018

1 reference

Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial

21 January 2018

1 reference

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery

21 January 2018

1 reference

Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial

21 January 2018

1 reference

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes

21 January 2018

1 reference

Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs.

21 January 2018

1 reference

The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010.

21 January 2018

1 reference

Type 2 diabetes mellitus and obesity in young adults: the extreme phenotype with early cardiovascular dysfunction.

21 January 2018

1 reference

Earlier onset of complications in youth with type 2 diabetes

21 January 2018

1 reference

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

Achievement of goals in U.S. diabetes care, 1999-2010.

21 January 2018

1 reference

Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study

21 January 2018

1 reference

Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study

21 January 2018

1 reference

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials

21 January 2018

1 reference

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes

21 January 2018

1 reference

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

21 January 2018

1 reference

Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know

21 January 2018

1 reference

A systematic review of the associations between dose regimens and medication compliance

21 January 2018

1 reference

The impact of treatment noncompliance on mortality in people with type 2 diabetes

21 January 2018

1 reference

Glycemic effectiveness and medication adherence with fixed-dose combination or coadministered dual therapy of antihyperglycemic regimens: a meta-analysis

21 January 2018

1 reference

21 January 2018

Adherence to Medication

1 reference

Measuring beliefs about taking hypoglycaemic medication among people with Type 2 diabetes.

21 January 2018

1 reference

Weight change and healthcare resource use in English patients with type 2 diabetes mellitus initiating a new diabetes medication class

21 January 2018

1 reference

Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort database

21 January 2018

1 reference

Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes

21 January 2018

1 reference

Structured patient education: the diabetes X-PERT Programme makes a difference.

21 January 2018

1 reference

Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care

21 January 2018

1 reference

Influences on control in diabetes mellitus: patient, doctor, practice, or delivery of care?

21 January 2018

1 reference

Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude

21 January 2018

1 reference

Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people

21 January 2018

1 reference

Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes

21 January 2018

1 reference

21 January 2018

1 reference

Diabetes care for Medicare beneficiaries. Attitudes and behaviors of primary care physicians

21 January 2018

1 reference

Reasons for not intensifying medications: differentiating "clinical inertia" from appropriate care

21 January 2018

1 reference

Commentary--improving diabetes care by combating clinical inertia.

21 January 2018

1 reference

Clinical inertia in management of T2DM.

21 January 2018

1 reference

Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for Diabetes

21 January 2018

1 reference

Population intermediate outcomes of diabetes under pay-for-performance incentives in England from 2004 to 2008.

21 January 2018

1 reference

Use of a glucose algorithm to direct diabetes therapy improves A1C outcomes and defines an approach to assess provider behavior

21 January 2018

1 reference

Randomized controlled trial of an informatics-based intervention to increase statin prescription for secondary prevention of coronary disease.

21 January 2018

1 reference

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015

21 January 2018

1 reference

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

21 January 2018

1 reference

Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise

21 January 2018

1 reference

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis.

21 January 2018

1 reference

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

21 January 2018

1 reference

Glycaemic durability with dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of long-term randomised controlled trials

21 January 2018

1 reference

Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial

21 January 2018

1 reference

Rationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE).

21 January 2018

1 reference

Differential Control of Systolic and Diastolic Blood Pressure

21 January 2018

1 reference

Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled

21 January 2018

1 reference

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DOM.12760

1 reference

7 September 2017

1 reference